Adrenal Insufficiency – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Adrenal Insufficiency – Drugs In Development, 2024 report and make more profitable business decisions.
Adrenal insufficiency or Addison’s disease is the inability of adrenal glands to make certain hormones like cortisol and aldosterone. It is caused by an autoimmune disease or by suddenly stopping a steroid treatment without weaning. The most common symptoms are fatigue, muscle weakness, loss of appetite, weight loss, and abdominal pain. It can be diagnosed with the help of blood tests, CT scans, and MRI. Glucocorticoids, mineralocorticoids, and androgen replacement are helpful in treating it.
The Adrenal Insufficiency drugs in development market research report provide comprehensive information on the therapeutics under development for Adrenal Insufficiency, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Adrenal Insufficiency and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Adrenal Insufficiency | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 5 molecules, with 5 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Adrenal Insufficiency therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Adrenal Insufficiency pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Adrenal Insufficiency treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Antares Pharma IncCitrine (Shanghai) Co Ltd
Crossject SA
Diurnal Group Plc
Eton Pharmaceuticals Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Adrenal Insufficiency reports